Recent ACON News
- Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash • GlobeNewswire Inc. • 11/21/2024 01:00:00 PM
- Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/10/2024 11:00:00 AM
- Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes • GlobeNewswire Inc. • 09/27/2024 10:57:00 AM
- PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology • GlobeNewswire Inc. • 09/13/2024 12:30:00 PM
- Aclarion Provides Corporate Update on Nociscan AI Technology Milestones • GlobeNewswire Inc. • 09/12/2024 10:57:00 AM
- Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial • GlobeNewswire Inc. • 09/10/2024 10:57:00 AM
- Aclarion Added to PRISM Emerging Medical Devices Index • GlobeNewswire Inc. • 09/06/2024 03:27:33 PM
- Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market • GlobeNewswire Inc. • 09/05/2024 10:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:01:26 PM
- Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey • GlobeNewswire Inc. • 08/29/2024 10:57:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/26/2024 08:02:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:58:12 PM
- Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans • GlobeNewswire Inc. • 08/21/2024 11:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:56:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2024 08:01:01 PM
- Aclarion to Present at August 20th Virtual Investor Summit Microcap Event • GlobeNewswire Inc. • 08/15/2024 01:48:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 07:34:17 PM
- Aclarion Announces First Commercial Agreement in Michigan • GlobeNewswire Inc. • 08/14/2024 12:08:00 PM
- Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK • GlobeNewswire Inc. • 08/13/2024 01:07:00 PM
- Form 253G3 - • Edgar (US Regulatory) • 08/13/2024 01:05:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/13/2024 11:56:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:02:13 PM
- Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK • GlobeNewswire Inc. • 06/26/2024 12:30:00 PM
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM